N
OPTN

Natixis’s OptiNose OPTN Stock Holding History

Natixis’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,333
Closed -$57K – 1285
2021
Q4 		$57K Hold
2,333
– – ﹤0.01% 1198
2021
Q3 		$105K Hold
2,333
– – ﹤0.01% 1164
2021
Q2 		$109K Buy
2,333
+1,000
+75% +$51.1K ﹤0.01% 829
2021
Q1 		$74K Buy
+1,333
New +$81.1K ﹤0.01% 1044

Other funds holding OPTN

MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Natixis's OPTN Position: Q1 2022 in Review

Natixis sold out of OptiNose (OPTN) in Q1 2022, closing a stake of 2,333 shares — an estimated $57K sold.

Natixis first reported a position in OPTN in Q1 2021 and held it in 4 quarters. The position peaked at $109K in Q2 2021. 44 funds tracked by Wall St. Rank hold OPTN as of Q1 2022.

  • Natixis reported no remaining OptiNose position as of Q1 2022 after selling out during the quarter.
  • Natixis sold 2,333 OptiNose shares in Q1 2022, an estimated $57K.
  • Natixis first reported a position in OptiNose in Q1 2021 and held it in 4 quarters.
  • Natixis's OptiNose position peaked at $109K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q1 2022.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.